Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population
<p>Abstract</p> <p>Background</p> <p>Gout prevalence increased in recent years to become one of the most common causes of inflammatory arthritis in most industrialised countries. Comorbidities may affect the disease severity and treatment patterns. We describe the main...
Main Authors: | Plana Estel, Primatesta Paola, Rothenbacher Dietrich |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | BMC Musculoskeletal Disorders |
Online Access: | http://www.biomedcentral.com/1471-2474/12/103 |
Similar Items
-
Incident gout and weight change patterns: a retrospective cohort study of US adults
by: Lu Bai, et al.
Published: (2021-03-01) -
Gout and comorbidity: a nominal group study of people with gout
by: Jasvinder A. Singh
Published: (2017-09-01) -
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
by: Thomas Bardin, et al.
Published: (2017-07-01) -
Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population
by: Jasvinder A. Singh, et al.
Published: (2019-03-01) -
COMORBIDITY AND GOUT: ASSOCIATION BETWEEN HYPERURICEMIA AND BLOOD PARAMETERS AS A PREDICTOR OF GOUT
by: Erna Islamagic, et al.
Published: (2020-04-01)